Well Characterized Biologics & Biological Assays is now part of BioProcess International
September 23-26, 2024,
Hynes Convention Center in Boston, USA
September 23-26, 2024,
Hynes Convention Center in Boston, USA
We Are Currently Accepting Proposals for Speaker Presentations
To submit a proposal, you will need to select the conference topic you are interested in, indicate whether your presentation will include a CASE STUDY or NEW DATA, provide a 60-90 word summary of your proposed talk, and provide your full contact details. Deadline: April 30, 2018.
We are looking for presentations in the following topic areas:
Well Characterized Biologicals Track
- Case Studies of Protein Characterization and Product Comparability
- Characterization Strategies for ADCs, Bispecifics, Fusion Proteins
- Characterization Strategies and Case Studies for New Modalities (Cell & Gene Therapies etc.)
- Biosimilar, Biobetter and Interchangeable Characterization and Comparability
- Analytical Strategies for Host Cell Proteins and Particulates
- Strategies for Higher Order Structure
- Control of Product and Process Variants and Impurities
- Emerging Analytical Technologies and Applications (including mass spec and other technologies and the interface between mass spec and other equipment)
- Regulatory Perspectives on Common Pitfalls in Your Analytical and CMC Studies
- Comparability Strategies across the Product Lifecycle
- New Developments for the Multi-Attribute Method
- Methods for Particle Characterization
- Characterization Case Studies of Vaccines, Combination Products, Complex Molecules
Biological Assays Track
- CMC Biological Assay Case Studies
- Automation of Bioassays
- Use of DoE Approaches in Bioassay Development
- Method Lifecycle Development for Bioassays
- Method Bridging and Method Tech Transfer for Bioassays
- QbD and Continuous Method Verification for Bioassays
- How to Maintain a State of Method Control for Legacy Bioassays
- Monitoring Stability of Reference Standards for Potency Assays
- Bioassay Development for Biosimilars
- Bioassays for ADCs, Bispecifics, Cell Therapies and DNA/RNA Therapeutics
- Statistical Approaches for Biological Assays